Back
RxSight Vs. Tandem Diabetes Care Industry Stock Comparison
Sell
30
RXST
RxSight
Last Price:
53.42
Seasonality Move:
-0.72%
Sell
38
TNDM
Tandem Diabetes Care
Last Price:
44.45
Seasonality Move:
-16.6%
Sell
30
RxSight (RXST)
is a Sell
Is RxSight a Buy, Sell or Hold?
- The current RxSight [RXST] share price is $53.53. The Score for RXST is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RXST is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Tandem Diabetes Care (TNDM)
is a Sell
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $44.45. The Score for TNDM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- TNDM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RXST Stock Price Chart
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $44.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNDM is experiencing buying pressure, which is a positive indicator for future bullish movement.
RXST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 49.79 | Sell |
| Chaikin Money Flow: | -188693 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.92 - 55.66) | Sell |
| Bollinger Bands (100): | (49.41 - 59.95) | Sell |
TNDM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 55.82 | Buy |
| Chaikin Money Flow: | 725199 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.07 - 44.55) | Buy |
| Bollinger Bands (100): | (39.53 - 47.73) | Buy |
RXST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.61 | Sell |
| 20-day SMA: | 54.67 | Sell |
| 50-day SMA: | 50.74 | Buy |
| 200-day SMA: | 51.2 | Buy |
| 8-day EMA: | 54.47 | Sell |
| 20-day EMA: | 53.96 | Sell |
| 50-day EMA: | 53.09 | Buy |
| 200-day EMA: | 48.8 | Buy |
TNDM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.04 | Buy |
| 20-day SMA: | 43.19 | Buy |
| 50-day SMA: | 42.32 | Buy |
| 200-day SMA: | 35.87 | Buy |
| 8-day EMA: | 43.23 | Buy |
| 20-day EMA: | 42.91 | Buy |
| 50-day EMA: | 42.53 | Buy |
| 200-day EMA: | 38.06 | Buy |
RxSight Earnings Growth & RXST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.07 per share, an increase this year of $0.85 per share, and an increase next year of $0.38 per share.
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.13 per share, an increase this year of $0.08 per share, and an increase next year of $0.55 per share.
RxSight Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tandem Diabetes Care Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||